Drug
URO-902 clinical trials
Also written URO-902.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2007
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2007 (1)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2019 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses URO-902 is read from its arms, and is right about nine times in ten.
Testing it · 4
- URO-902 in Female Subjects With Overactive Bladder and Urge Urinary IncontinenceCompletedPhase 2Urovant Sciences GmbHNCT04211831Written as URO-902
- Phase 2A Clinical Trial Evaluating the Potential Activity and Safety of hMaxi-K Gene for EDCompletedPhase 2Urovant Sciences GmbHNCT02713789Written as hMaxi-K Single Treatment/ 2 escalating dose levels (8000 µg and 16000 µg injection)
- Safety Study of hMaxi-K Gene Transfer to Treat Overactive Bladder and Detrusor OveractivityTerminatedPhase 1Urovant Sciences GmbHNCT00495053Written as hMaxi-K
- Phase 1 Study With OAB Assessing the Safety and Activity of hMaxi-K Gene TransferCompletedPhase 1Urovant Sciences GmbHNCT01870037Written as hMaxi-K